<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-molecules-26-00501">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rodríguez-Enríquez</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Costas-Lago</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Besada</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Alonso-Pena</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Torres-Terán</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Viña</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fontenla</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Sturlese</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Moro</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Quezada</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson’s disease therapy</article-title>
  <source>Bioorg. Chem.</source>
  <year>2020</year>
  <volume>104</volume>
  <fpage>104203</fpage>
  <pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104203</pub-id>
  <pub-id pub-id-type="pmid">32932120</pub-id>
 </element-citation>
</ref>
